Abstract | PURPOSE: METHODS: Two patients with retinitis pigmentosa and one with Usher syndrome type 2 who participated in a phase 2 clinical trial received CNTF delivered by an encapsulated cell technology implant in one eye and sham surgery in the contralateral eye. Patients were followed longitudinally over 30 to 35 months. Adaptive optics scanning laser ophthalmoscopy (AOSLO) provided high-resolution images at baseline and at 3, 6, 12, 18, and 24 months. AOSLO measures of cone spacing and density and optical coherence tomography measures of retinal thickness were correlated with visual function, including visual acuity (VA), visual field sensitivity, and full-field electroretinography (ERG). RESULTS: No significant changes in VA, visual field sensitivity, or ERG responses were observed in either eye of the three patients over 24 months. Outer retinal layers were significantly thicker in CNTF-treated eyes than in sham-treated eyes (P < 0.005). Cone spacing increased by 2.9% more per year in sham-treated eyes than in CNTF-treated eyes (P < 0.001, linear mixed model), and cone density decreased by 9.1%, or 223 cones/degree(2) more per year in sham-treated than in CNTF-treated eyes (P = 0.002, linear mixed model). CONCLUSIONS:
|
Authors | Katherine E Talcott, Kavitha Ratnam, Sanna M Sundquist, Anna S Lucero, Brandon J Lujan, Weng Tao, Travis C Porco, Austin Roorda, Jacque L Duncan |
Journal | Investigative ophthalmology & visual science
(Invest Ophthalmol Vis Sci)
Vol. 52
Issue 5
Pg. 2219-26
(Apr 06 2011)
ISSN: 1552-5783 [Electronic] United States |
PMID | 21087953
(Publication Type: Clinical Trial, Phase II, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Ciliary Neurotrophic Factor
- Drug Implants
|
Topics |
- Adult
- Ciliary Neurotrophic Factor
(administration & dosage)
- Disease Progression
- Drug Implants
- Electroretinography
- Enzyme-Linked Immunosorbent Assay
- Female
- Follow-Up Studies
- Humans
- Male
- Ophthalmoscopy
- Prospective Studies
- Retinal Cone Photoreceptor Cells
(pathology)
- Retinitis Pigmentosa
(drug therapy, physiopathology)
- Tomography, Optical Coherence
- Usher Syndromes
(drug therapy, physiopathology)
- Visual Acuity
(physiology)
- Visual Fields
(physiology)
|